| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $405.9M | +21.7% |
| Cost of Revenue | $91.5M | +19.9% |
| Gross Profit | $314.4M | +22.2% |
| R&D Expense | $102.8M | +29.2% |
| SG&A Expense | $87.9M | +11.2% |
| Operating Income | -$60.4M | +12.9% |
| Interest Expense | $3.5M | +28.0% |
| Pre-tax Income | -$61.3M | +6.8% |
| Income Tax | $670K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $86.4M | +73.7% |
| Accounts Receivable | $84.0M | +32.4% |
| Current Assets | $210.2M | +7.3% |
| Total Assets | $428.3M | +8.0% |
| Current Liabilities | $220.8M | +21.9% |
| Long-term Debt | $25.0M | -54.5% |
| Total Liabilities | $261.7M | +3.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $26.3M | +307.7% |
| Capital Expenditures | $3.0M | +42.3% |
| Investing Cash Flow | $40.7M | +147.0% |
| Financing Cash Flow | -$30.3M | -156.2% |
| Free Cash Flow | $23.4M | +433.2% |
| +3.2% |
| Net Income | -$62.0M | +6.7% |
| EPS (Diluted) | -$1.09 | +8.4% |
| Stockholders' Equity |
| $166.6M |
| +15.5% |